Our data at ASH 2025 raises the bar for patient and physician expectations of what’s possible. Our long-term data drives confidence in duration of response in CLL treatment decisions,” said Lai Wang, ...
Jay Leno, whose longtime wife, Mavis Leno, suffers from dementia, opened up about his caretaking journey during an interview ...
Company starts enrollment in Romania for Phase 2 THIO-101 Part C study of ateganosine as a treatment for advanced non-small cell lung cancer ...
Cultivated meat cells today can behave more like high-water, loose ingredients than structured meat. Germany-based texturizing specialist Hydrosol is testing how its systems can firm and shape these ...
Cancer research, drug safety testing and aging biology may all gain a major boost from a new fluorescent sensor developed at ...
Cytek Biosciences has recurring revenue growth, improving margins, and ample cash that should continue compounding ...
Following the first Phase 3 study of HyBryte(TM) for the treatment of CTCL, the FDA and the EMA indicated that they would require a second successful Phase 3 trial to support mark ...
The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...
For example, naïve T cells increase in size before undergoing a burst of proliferation, while liver and fat cells enlarge or contract in response to nutrient availability. In these cases, size changes ...
The U.S. FDA on Thursday granted traditional approval for Darzalex Faspro, an injectable version of the multiple myeloma ...
A previously unknown type of DNA damage in the mitochondria, the tiny power plants inside our cells, could shed light on how ...
When human cells lack oxygen, they must react. Without oxygen, the metabolism can hardly generate energy, and many vital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results